BiondVax to Present on October 8 at the Aegis Growth Conference

Press Release
Written By

Ness Ziona, Israel – October 6, 2015 – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) announced today that BiondVax’s CEO, Dr. Ron Babecoff, will participate in the Aegis Growth Conference, taking place at The Encore at Wynn Hotel in Las Vegas, NV from October 7-9, 2015.BiondVax’s CEO, Dr. Ron Babecoff, is scheduled to present on Thursday, October 8, 2015 at 2pm Pacific Time.  The corporate presentation which Dr. Babecoff will present at the conference is available for download from the investor relations section of BiondVax’s website.At the conference there will be an opportunity for investors to meet one-on-one with Dr. Ron Babecoff. Investors interested in meeting with management should contact the Investor Relations team at BiondVax.

Previous

UNISEC Press Release: UNISEC consortium including BiondVax started a clinical trial for a Universal Influenza Vaccine
Next

BiondVax Establishes Capability for the Manufacture of Clinical Grade Universal Flu Vaccine for Phase III Clinical Trials